https://doi.org/10.22037/jcma.v5i1.29760

Review of therapeutic agents for the treatment of COVID-19

authors:

avatar Shadi Ziaie 1 , avatar Mehran Kouchek ORCID 2 , avatar Mir Mohammad Miri 2 , avatar Sara Salarian ORCID 2 , avatar Seyed pouzhia Shojaei 2 , avatar Mehrdad Haghighi ORCID 3 , avatar Mohammad Sistanizad ORCID 1 , *

Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Critical Care Medicine Ward, Anesthesiology Department, Imam Hossein (A.S.) Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Infectious Disease, Imam Hossein (A.S.) Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Journal of Cellular & Molecular Anesthesia: Vol.5, issue 1; e151378
published online: April 09, 2020
article type: Letter

How To Cite Ziaie S, Kouchek M, Miri M M, Salarian S, Shojaei S P, et al. Review of therapeutic agents for the treatment of COVID-19. J Cell Mol Anesth. 2020;5(1):e151378. https://doi.org/10.22037/jcma.v5i1.29760.

Abstract

In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China, named coronavirus disease 2019 (COVID -19) which has been spreading in 204 countries. In this review, the mains pharmaceutical option quoted previously and especially available for ICU patients are reviewed.

References

  • 1.

    References are in the PDF file of the article.